Nabsys, Inc., has initiated its transition from technology development to product commercialization by announcing the appointment of Stan Rose, Ph.D., as the company's first chief commercial officer. Nabsys is also announcing that Jeffrey Sklar, M.D., Ph.D., has agreed to join the company's scientific advisory board.
Nabsys is pioneering the development of a novel technology with broad applicability for DNA analysis, called Positional Sequencing. The Nabsys platform uses solid-state nanodetectors to analyze single DNA molecules by electronic detection, revealing both ...
read more